LifeMD Sees Q2 Sales $47.000M-$50.000M vs $53.989M Est

Benzinga Newsdesk www.benzinga.com Positive 81.1%

Neg 0% Neu 0% Pos 81.1%

LifeMD (NASDAQ:LFMD) sees Q2 sales of $47.000 million-$50.000 million vs $53.989 million analyst estimate.

Comments

No comments yet. Be the first!